| Vector-borne infectious diseases | Lifetime | 7 | FR 2 | 99.88 |
| Bacterial Identification and Susceptibility Testing | Lifetime | 18 | FR 2 | 99.80 |
| Viral Infections and Vectors | Lifetime | 47 | FR 6 | 99.72 |
| Yersinia bacterium, plague, ectoparasites research | Lifetime | 17 | FR 3 | 99.47 |
| Bartonella species infections research | Lifetime | 3 | FR 2 | 99.53 |
| Genomics and Phylogenetic Studies | Lifetime | 99 | FR 5 | 99.64 |
| Streptococcal Infections and Treatments | Lifetime | 42 | FR 3 | 99.56 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 77 | FR 5 | 99.60 |
| Diphtheria, Corynebacterium, and Tetanus | Lifetime | 26 | FR 3 | 98.09 |
| COVID-19 Clinical Research Studies | Lifetime | 491 | FR 26 | 98.06 |
| Antibiotic Resistance in Bacteria | Lifetime | 338 | FR 23 | 98.88 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 486 | FR 15 | 98.38 |
| Rabies epidemiology and control | Lifetime | 96 | FR 9 | 98.43 |
| Dermatological diseases and infestations | Lifetime | 51 | FR 6 | 98.13 |
| Vector-Borne Animal Diseases | Lifetime | 233 | FR 15 | 98.33 |
| Gut microbiota and health | Lifetime | 554 | FR 29 | 98.19 |
| SARS-CoV-2 detection and testing | Lifetime | 171 | FR 5 | 96.50 |
| Mycobacterium research and diagnosis | Lifetime | 559 | FR 35 | 97.39 |
| Mosquito-borne diseases and control | Lifetime | 788 | FR 44 | 97.95 |
| Insect symbiosis and bacterial influences | Lifetime | 252 | FR 19 | 97.58 |
| Antimicrobial Resistance in Staphylococcus | Lifetime | 938 | FR 51 | 96.31 |
| Actinomycetales infections and treatment | Lifetime | 99 | FR 7 | 94.12 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 843 | FR 34 | 94.69 |
| Infections and bacterial resistance | Lifetime | 253 | FR 16 | 91.27 |
| Bacillus and Francisella bacterial research | Lifetime | 868 | FR 57 | 89.59 |
| Legionella and Acanthamoeba research | Lifetime | 532 | FR 36 | 88.36 |
| Whipple's Disease and Interleukins | Lifetime | 163 | FR 19 | 85.29 |
| Enterobacteriaceae and Cronobacter Research | Lifetime | 758 | FR 64 | 85.66 |
| Otolaryngology and Infectious Diseases | Lifetime | 539 | FR 14 | 84.09 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 409 | FR 15 | 98.29 |
| COVID-19 Clinical Research Studies | 2021-2025 | 604 | FR 28 | 97.34 |
| SARS-CoV-2 detection and testing | 2021-2025 | 154 | FR 6 | 96.22 |
| Bacterial Identification and Susceptibility Testing | 2021-2025 | 113 | FR 8 | 95.83 |
| Genomics and Phylogenetic Studies | 2021-2025 | 427 | FR 13 | 93.98 |
| Vector-borne infectious diseases | 2021-2025 | 189 | FR 12 | 93.89 |
| Infective Endocarditis Diagnosis and Management | 2021-2025 | 408 | FR 26 | 94.75 |
| Viral Infections and Vectors | 2021-2025 | 732 | FR 33 | 90.89 |
| Yersinia bacterium, plague, ectoparasites research | 2021-2025 | 331 | FR 16 | 75.65 |
| Planarian Biology and Electrostimulation | 2021-2025 | 136 | FR 7 | 72.78 |
| Bacillus and Francisella bacterial research | 2021-2025 | 757 | FR 31 | 67.54 |
| Bartonella species infections research | 2021-2025 | 105 | FR 7 | 65.53 |
| Infections and bacterial resistance | 2021-2025 | 236 | FR 10 | 61.99 |
| Enterobacteriaceae and Cronobacter Research | 2021-2025 | 348 | FR 15 | 59.63 |
